A new European Union regulation now tightens the rules governing the use of certain substances in cosmetic products, adding another amendment to the EU Cosmetics Regulation (EC) No 1223/2009 framework that formulators and regulatory teams will need to action.

The measure, reported by bechbruun.com, follows the established EU pattern: the European Commission periodically adapts Annexes II through VI of the Cosmetics Regulation in response to scientific opinions, typically from the Scientific Committee on Consumer Safety (SCCS). Each such amendment carries direct legal force in all member states without requiring national transposition, which means compliance clocks start on the date the regulation enters into force.

For product owners, the immediate question is scope.

Which products are affected?

Any amendment to the restricted-substance annexes triggers a chain of compliance work. Responsible persons must screen their portfolios against the newly tightened entries, and distributors holding non-compliant stock face the standard two-stage deadlines the Commission applies: one date after which placing non-compliant products on the EU market is prohibited, and a later date after which even existing inventory cannot be made available to end users.

The practical workload falls into three buckets:

• Reformulation for products where a newly restricted substance sits above permitted limits or in newly covered product categories;
• Label and PIF updates where warnings, concentration ceilings or entry wording change;
• Supplier verification to confirm whether raw materials and fragrance compounds fall within the revised restrictions.

What should compliance teams do now?

Because the regulation amends the annexes directly, waiting for consolidated guidance is a losing strategy. Teams should pull the amended annex text from the Official Journal, run a substance-level gap analysis against formulas in the Product Information File, and flag any SCCS opinions pending implementation — the Commission's omnibus amendments increasingly batch multiple substances into a single regulation, so one legal instrument can touch several ingredient categories at once.

Contract manufacturers and private-label brands carry particular exposure here, since a single restricted substance can run through dozens of SKUs across multiple brand owners. Notification duties under the EU Cosmetic Products Notification Portal (CPNP) may also need revisiting if formulations change in response.

What comes next?

The trade's attention now shifts to the implementing timeline: watch the Official Journal publication date, count the standard grace periods for make-available deadlines, and track the next SCCS opinion cycle — several substances now in re-evaluation could land in a follow-up omnibus amendment within months.